Table 4.
ηp2 | Estimate [95% CI] | p | |
---|---|---|---|
| |||
Sex*APOE4 a | |||
| |||
Global PIB SUVR | |||
Sex | .009 | 0.105 [−0.102, 0.313] | .32 |
APOE4 | <.001 | 0.015 [−0.176, 0.207] | .87 |
Sex*APOE4 | .001 | 0.044 [−0.223, 0.310] | .75 |
Temporal Meta-ROI FTP SUVR | |||
Sex | .099 | 0.414 [0.176, 0.652] | <.001 |
APOE4 | .027 | 0.193 [−0.028, 0.413] | .09 |
Sex*APOE4 | .040 | −0.330 [−0.636, −0.024] | .035 |
Entorhinal FTP SUVR | |||
Sex | .10 | 0.272 [0.118, 0.425] | <.001 |
APOE4 | .072 | 0.209 [0.067, 0.351] | .004 |
Sex*APOE4 | .024 | −0.165 [−0.362, 0.033] | .10 |
Sex*Age b | |||
Global PIB SUVR | |||
Sex | .043 | 0.146 [0.018, 0.273] | .025 |
Age | <.001 | −0.001 [−0.011, 0.010] | .88 |
Age*Sex | .001 | −0.002 [−0.016, 0.0118] | .77 |
Temporal Meta-ROI FTP SUVR | |||
Sex | .070 | 0.221 [0.071, 0.370] | .004 |
Age | .083 | −0.020 [−0.032, −0.008] | .002 |
Age*Sex | .004 | 0.006 [−0.011, 0.022] | .50 |
Sex*CDR-SoB c | |||
Global PIB SUVR | |||
Sex | .043 | 0.146 [0.019, 0.274] | .025 |
CDR-SoB | <.001 | −0.002 [−0.039, 0.035] | .92 |
Sex*CDR-SoB | .004 | 0.020 [−0.040, 0.081] | .51 |
Temporal Meta-ROI FTP SUVR | |||
Sex | .070 | 0.221 [0.072, 0.370] | .004 |
CDR-SoB | .132 | 0.054 [0.011, 0.098] | .015 |
Sex*CDR-SoB | .003 | −0.021 [−0.092, 0.051] | .57 |
Reference levels are male and ε4 non-carrier for sex and APOE4 status, respectively. ηp2: partial eta-squared. CDR-SoB = Clinical Dementia Rating Sum of Boxes.
APOE data available on 56 males and 59 females (total n=115). APOE4 is coded as either an ε4 carrier or non-carrier. Models controlled additionally for age and Clinical Dementia Rating Sum of Boxes.
Models controlled additionally for Clinical Dementia Rating Sum of Boxes.
Models controlled additionally for age.